Clinical Trial Update: Safety and Efficacy of Sirolimus for HIV Reservoir Reduction in Individuals on Suppressive Antiretroviral Therapy (ART) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial evaluating sirolimus for reducing HIV reservoirs in individuals on suppressive ART; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-12-30